PRTA
Prothena Corp. Plc
NASDAQ · Healthcare · Biotechnology · IE
$8.47
−4.62%Oct 2, 2026, 20:29 UTC
Prothena Corp Public Ltd Co Chief Development Officer Chad J. Swanson, Ph.D. resigned, effective October 9, 2026.
Aug 6, 2026, 20:05 UTC
Prothena reported financial results for the second quarter and first six months of 2026.
Source: